About Contact Us Careers

Acute Sinusitis Treatment Market Trends

Request Free Sample Copy

Report ID: 3117
Published Date: Sep 02, 2024
Report Format: PDF, PPT

Buy Now

Acute Sinusitis Treatment Market Trends

Growth Drivers

Increasing Cases of Sinusitis Globally
Rising Demand for Fast Relief Treatment Solutions for Sinus

Challenges

Circulation of Generic Drugs in the Market

Acute Sinusitis Market: Key Insights

Base Year	2023
Forecast Year	2024-2036
CAGR	7.3%
Base Year Market Size (2023)	USD 2.24 billion
Forecast Year Market Size (2036)	USD 5.6 billion
Regional Scope	North America (U.S., and Canada) Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific) Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Latin America (Mexico, Argentina, Brazil, Rest of Latin America) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Acute Sinusitis Market Size & Share, Growth Forecast 2036

Author Credits: Radhika Pawar

Report ID: 3117
Published Date: Sep 02, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of acute sinusitis is estimated at USD 2.37 billion.

Acute Sinusitis Market size was over USD 2.24 billion in 2023 and is anticipated to reach USD 5.6 billion by 2036, growing at around 7.3% CAGR during the forecast period i.e., between 2024-2036. Rising prevalence of sinusitis and growing R&D investment for medical research will impel the market growth.

North America is predicted to hold largest revenue share by 2036, on the back of high prevalence of sinusitis in the region.

The major players in the market are Novartis AG, F. Hoffmann-La Roche Ltd., Amgen Inc., Cerecor, Inc., Bausch Health Companies Inc., and others.

Inquiry Before Buying Request Free Sample